Organogenesis Holdings (ORGO) P/E Ratio
P/E Ratio as of Jul 3, 2025: -28.45
Average-22.58
Median-22.12
Minimum-28.45
Maximum-18.81
-28.45
Past Month-10.65 (59.83%)
The P/E ratio for Organogenesis Holdings (ORGO) is -28.45 as of Jul 3, 2025. This represents a decrease of -115.18% compared to its 12-month average P/E ratio of 187.42. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Organogenesis Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Organogenesis Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Organogenesis Holdings to industry peers.
Organogenesis Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Organogenesis Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Organogenesis Holdings to industry peers.
Organogenesis Holdings (ORGO) P/E Ratio Insights
See Organogenesis Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Organogenesis Holdings (ORGO)
Order type
Buy in
Order amount
Est. shares
0 shares
Organogenesis Holdings (ORGO) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $3.78 | -25.30 |
| Jun 2, 2025 | $2.66 | -17.80 |
| May 1, 2025 | $4.96 | 885.71 |
| Apr 1, 2025 | $4.28 | 764.29 |
| Mar 3, 2025 | $5.41 | 966.07 |
| Feb 3, 2025 | $3.41 | -60.04 |
| Jan 2, 2025 | $3.03 | -53.35 |
Organogenesis Holdings (ORGO) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -28.45 | -49.50% |
| 2024 | -56.34 | -234.72% |
| 2023 | 41.82 | +608.81% |
| 2022 | 5.90 | -54.62% |
| 2021 | 13.00 | -75.66% |
| 2020 | 53.40 | — |
FAQs About Organogenesis Holdings (ORGO) P/E ratio
The latest P/E ratio of Organogenesis Holdings (ORGO) is -28.45, as of Jul 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Organogenesis Holdings’s last 12-month average P/E ratio is 187.42, compared to its current P/E ratio of -28.45. This reflects a decrease of -115.18%.
Organogenesis Holdings’s current P/E ratio of -28.45 is lower than its last 12-month average P/E of 187.42. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Organogenesis Holdings’s average P/E ratio over the last 3 years is 85.82. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Organogenesis Holdings’s average P/E ratio over the last 5 years is 58.25. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.